Andrew Spaventa
Chief Executive Officer · Singular Genomics Systems, Inc.
IndividualSelling only
- 2024
- Dec 17, 2024
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Andrew Spaventa's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- GIC Private Ltd - $1.81B in MDLN purchases and sales in the last 12 months
- Carlyle Group Inc. - $1.63B in MDLN purchases and sales in the last 12 months
- Carlyle Mozart Coinvestment Holdings, L.P. - $1.63B in MDLN purchases and sales in the last 12 months
- WARBURG PINCUS CO. - $1.12B in SHC purchases and sales in the last 12 months
- CP Circle ML Holdco GP, LLC - $1.07B in MDLN purchases and sales in the last 12 months
- TC Group Cayman Investment Holdings, L.P. - $1.07B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Spaventa?
Andrew Spaventa is a corporate insider, tracked as Chief Executive Officer of Singular Genomics Systems, Inc. (OMIC). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Andrew Spaventa last file a Form 4?
The most recent primary Form 4 on record is dated 17 December 2024, one of 2 filings going back to 2024.
Has Andrew Spaventa been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($19K) across all tracked filings.
